4/A

PRIMARY DOCUMENT

Company: SELLAS Life Sciences Group, Inc.
Filed: September 19, 2014
Period of Report: June 30, 2014
Accession Number: 0001250853-14-000119

View Document ↗ View on SEC.gov ↗